School of Medicine
Showing 11,541-11,560 of 12,937 Results
-
Ummey Hani, MBBS, MD
Postdoctoral Scholar, Neurosurgery
BioHani is a Postdoctoral Research Fellow at Stanford University in the Neurosurgical Artificial Intelligence and Machine Learning Laboratory. She earned her medical degree from Sindh Medical College, Pakistan, and completed her internship at the Aga Khan University, where she was recognized as Class Valedictorian and among the top five interns of 2022. She then pursued a two-year postdoctoral fellowship at Carolina Neurosurgery and Spine Associates in Charlotte, North Carolina, affiliated with Wake Forest University School of Medicine, focusing on spine surgery outcomes and biomechanics. Before joining Stanford, she served as Junior Research Faculty for neuro-oncology research at the Aga Khan University in Karachi, Pakistan.
Hani’s research spans neuro-oncology, spine surgery, biomechanics, and the application of AI/ML in neurosurgical innovation. With a deep commitment to academic neurosurgery, she is currently working towards securing a neurosurgical residency. -
Ndidi Unaka
Clinical Professor, Pediatrics
BioDr. Unaka is the inaugural Chief Health Equity Officer (CHEO) for Stanford Medicine Children’s Health (SMCH) and a Clinical Professor in the Department of Pediatrics at Stanford University School of Medicine. Prior to her transition to SMCH in July 2024, Dr. Unaka was a faculty member in the Division of Hospital Medicine at Cincinnati Children's Hospital. In addition to her clinical role as a pediatric hospitalist, Dr. Unaka served as the Associate Program Director of the Pediatric Residency Program from 2011 – January 2022. She served as the medical director of a 48- bed inpatient unit primarily for patients admitted to the Hospital Medicine service. In this role, Dr. Unaka was involved in several equity-oriented quality improvement initiatives which included work to identify, and address hunger among caregivers of hospitalized children insured by Medicaid.
Dr. Unaka worked on institution-level community health initiatives at Cincinnati Children’s. She served as the Medical Director of Quality Improvement and Data Analytics for Cincinnati Children’s Medicaid- focused, accountable care organization (HealthVine). In this role, she developed and led initiatives designed to improve the quality and efficiency of health care delivery to HealthVine’s patient population and helped lead the change management associated with the movement toward a population-health care model that improves quality, narrows equity gaps, streamlines care, and reduces costs. She helped define appropriate health care delivery, equity, and population health measures and quality benchmarks. Additionally, Dr. Unaka was a faculty lead within Cincinnati Children's Fisher Child Health Equity Center, and she specifically focused on working with operations leaders to ensure equity was embedded within all strategic plans, goals, and metrics across all sites of care. Dr. Unaka partnered with several colleagues to lead system-wide quality improvement initiatives including work accelerated via learning networks. She was the co-lead of Cincinnati Children's Health Equity Network (HEN), an initiative borne out of the pursuit of excellent and equitable health outcomes for youth in Greater Cincinnati. The HEN supports clinical teams seeking to eliminate disparities in child health outcomes by race, ethnicity, and/or socioeconomic status via targeted interventions and best practices by addressing both medical and social factors known to confer poor health outcomes. -
Rachel Allison Ungar
Postdoctoral Scholar, Biomedical Ethics
BioRachel Ungar, PhD, is a Postdoctoral Fellow in the Stanford Training Program in ELSI Research (T32) at the Stanford Center for Biomedical Ethics. Her graduate research was in computational genomics focused on multiomics approaches in Stephen Montgomery’s lab. She was an active member of the Undiagnosed Diseases Network, and GREGoR rare disease consortia focused on transcriptomic methods and data standards. She also examined the impact of rare variants and sex on the X-chromosome. During her PhD, she co-created and taught a course expanding ethics education to bioscientists (GENE 220: Genetics, Ethics, and Society) and evaluated its impact. During her postdoc, Rachel aims to use her background to integrate genomics and ethics, beginning with ethical considerations for rare and undiagnosed disorders. Rachel received her PhD in Genetics at Stanford. She earned her Bachelor of Science in Biology at the University of Arkansas with minors in mathematics and computer science.
-
Crystal Unzueta, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Unzueta is a board-certified family medicine physician. She specializes in providing primary care services to people of all ages. Her services include annual check-ups, monitoring chronic conditions, and performing minor in-office procedures.
She is also a clinical assistant professor in the Stanford School of Medicine Department of Family Medicine.
Dr. Unzueta’s practice focuses on providing compassionate and comprehensive care. She specializes in providing bilingual and bicultural care for patients in underserved populations. She has traveled to Belize on a medical mission to provide free, basic primary care to vulnerable communities. Her mentoring work includes building a network of Latino medical students to help support each other throughout medical school. She has also worked on numerous volunteer projects, such as researching the benefits of a community yoga program for minorities in underserved areas. -
Alexander Eckehart Urban
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and of Genetics
Current Research and Scholarly InterestsComplex behavioral and neuropsychiatric phenotypes often have a strong genetic component. This genetic component is often extremely complex and difficult to dissect. The current revolution in genome technology means that we can avail ourselves to tools that make it possible for the first time to begin understanding the complex genetic and epigenetic interactions at the basis of the human mind.
